Purple Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	9.59	7.4	14.49	15.03	10.89	11.25
Short-Term Investments	0.86	1.12	0.92	16.65	36.31	46.56
Cash & Short-Term Investments	10.45	8.52	15.41	31.68	47.2	57.81
Cash Growth	65.94%	-44.69%	-51.35%	-32.88%	-18.35%	1215.24%
Accounts Receivable	-	-	-	0.43	-	0.5
Other Current Assets	0.32	0.38	0.38	1.14	1.27	0.98
Total Current Assets	10.77	8.91	15.79	33.26	48.47	59.28
Net Property, Plant & Equipment	0.45	0.29	0.47	0.68	0.9	0.97
Other Intangible Assets	27.84	27.84	28.04	20.68	20.48	20.48
Long-Term Investments	-	-	-	-	0.19	-
Other Long-Term Assets	28.29	28.13	28.51	21.37	0.16	3.07
Total Assets	39.06	37.04	44.3	54.62	70.2	83.8
Accounts Payable	0.61	1.46	3.53	2.13	1.47	1.2
Accrued Expenses	1.17	1.2	3.46	4.73	2.58	1.69
Current Portion of Leases	0.21	0.18	0.19	0.19	0.2	0.21
Other Current Liabilities	4.07	1.15	2.52	-	-	-
Total Current Liabilities	6.06	3.99	9.7	7.06	4.25	3.1
Long-Term Leases	0.05	-	0.16	0.32	0.55	0.69
Other Long-Term Liabilities	0.14	0.14	0.14	0.15	0.29	0.27
Total Long-Term Liabilities	0.19	0.14	0.3	0.47	0.84	0.95
Total Liabilities	6.25	4.13	10.01	7.52	5.09	4.05
Common Stock	-	-	-	-	123.95	-
Additional Paid-in Capital	181.17	178.41	172.5	166.35	37.64	157.77
Accumulated Other Comprehensive Income	-0.86	-0.86	-0.84	-0.85	-0.86	-0.86
Retained Earnings	-147.53	-144.69	-137.45	-117.57	-95.91	-77.52
Total Common Shareholders' Equity	32.77	32.86	34.21	46.91	64.83	79.39
Minority Interest	0.04	0.05	0.09	0.19	0.28	0.36
Shareholders' Equity	32.82	32.91	34.3	47.1	65.11	79.75
Total Liabilities & Equity	39.06	37.04	44.3	54.62	70.2	83.8
Total Debt	0.26	0.18	0.35	0.52	0.75	0.9
Net Cash (Debt)	10.2	8.34	15.06	31.17	46.45	56.91
Net Cash Growth	22.26%	-44.62%	-51.68%	-32.90%	-18.38%	1264.09%
Net Cash Per Share	-	5.09	13.61	34.48	2.64	4.95
Book Value	32.77	32.86	34.21	46.91	64.83	79.39
Book Value Per Share	-	20.04	30.91	51.89	3.69	6.90
Tangible Book Value	4.93	5.02	6.16	26.23	44.35	58.91
Tangible Book Value Per Share	-	3.06	5.57	29.01	2.52	5.12

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q